Complement activation, circulating protease inhibitors and pregnancy‐associated proteins in severe preeclampsia
- 22 August 1986
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 93 (8) , 811-814
- https://doi.org/10.1111/j.1471-0528.1986.tb07988.x
Abstract
Summary.Circulating protease inhibitors, pregnancy‐associated proteins and the split product of complement factor 3 (C3d) were measured in 14 women with severe pre‐eclampsia and their matched controls. Only the mean levels of antithrombin III were observed to be significantly lower in pre‐eclampsia (P<0.02).This publication has 18 references indexed in Scilit:
- Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardationBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Circulating immune complexes in hypertensive disorders of pregnancyJournal of Reproductive Immunology, 1984
- IMMUNE COMPLEXES IN SKIN OF PATIENTS WITH PRE-ECLAMPTIC TOXAEMIAThe Lancet, 1982
- Circulating antithrombins in pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Pregnancy-associated plasma protein A: Circulating levels during normal pregnancyAmerican Journal of Obstetrics and Gynecology, 1981
- Pregnancy-associated plasma protein-A: An inhibitor of the complement systemPlacenta, 1981
- STUDIES ON THE MATERNAL IMMUNE RESPONSE TO PLACENTAL ANTIGENS: ABSENCE OF A BLOCKING FACTOR FROM THE BLOOD OF ABORTION‐PRONE WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- A search for antigen-antibody complexes in pre-eclampsia: Further evidence against immunologic pathogenesisAmerican Journal of Obstetrics and Gynecology, 1978
- Circulating immune complexes in pre-eclampsia.BMJ, 1978
- Immunosuppression by human placenta lactogen (HPL) and the pregnancy-specific? 1-glycoprotein (SP-1)Archiv für Gynäkologie, 1977